The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes
Open accessAbstract
The 26 S proteasome is a high molecular mass proteinase complex that is built by at least 32 different protein subunits. Such protease complexes in bacteria and yeast are systems that undergo a highly sophisticated network of gene expression regulation. However, regulation of mammalian proteasome gene expression has been neglected so far as a possible control mechanism for the amount of proteasomes in the cell. Here, we show that treatment of cells with proteasome inhibitors and the concomitant impairment of proteasomal enzyme activity induce a transient and concerted up-regulation of all mammalian 26 S proteasome subunit mRNAs. Proteasome inhibition in combination with inhibition of transcription revealed that the observed up-regulation is mediated by coordinated transcriptional activation of the proteasome genes and not by post-transcriptional events. Our experiments also demonstrate that inhibitor-induced proteasome gene activation results in enhanced de novo protein synthesis of all subunits and in increased de novo formation of proteasomes. This phenomenon is accompanied by enhanced expression of the proteasome maturation factor POMP. Thus, our experiments present the first evidence that the amount of proteasomes in mammalia is regulated at the transcriptional level and that there exists an autoregulatory feedback mechanism that allows the compensation of reduced proteasome activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
A gated channel into the proteasome core particle.
Groll, M., Glickman, M. H., Finley, D. J., Bajorek, M., Köhler, A., Moroder, L., Rubin, D. M., & Huber, R. (2000) · Nature Structural Biology · doi:10.1038/80992 · Cited by 810
PROTEASES AND THEIR TARGETS IN ESCHERICHIA COLI
Gottesman, S. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.465 · Cited by 717
Antigen processing by the proteasome
Kloetzel, P.-M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056572 · Cited by 637
Self-citationStress–inducible responses and heat shock proteins: New pharmacologic targets for cytoprotection
Morimoto, R. I., & Santoro, M. G. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-833 · Cited by 632
Mitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599
Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., & Wolf, D. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25200 · Cited by 519
The base of the proteasome regulatory particle exhibits chaperone-like activity
Braun, B. C., Glickman, M., Kraft, R., Dahlmann, B., Kloetzel, P.-M., Finley, D., & Schmidt, M. (1999) · Nature Cell Biology · doi:10.1038/12043 · Cited by 478
Self-citation
Cited by
Protein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088
The ubiquitin-proteasome system
Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006) · Journal of Biosciences · doi:10.1007/bf02705243 · Cited by 758
Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Demo, S. D., Kirk, C. J., Aujay, M. A., Buchholz, T. J., Dajee, M., Ho, M. N., Jiang, J., Laidig, G. J., Lewis, E. R., Parlati, F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4086 · Cited by 678
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
Radhakrishnan, S. K., Lee, C. S., Young, P., Beskow, A., Chan, J. Y., & Deshaies, R. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.029 · Cited by 526
“Recent studies have indicated that elevated proteasome synthesis upon proteasome inhibition (which we refer to here as ‘‘bounce-back’’) is well conserved in higher eukaryotes (Lundgren et al., 2005; Meiners et al., 2003; Mitsiades et al., 2002).”
InfluentialRegulation of proteasome assembly and activity in health and disease
Rousseau, A., & Bertolotti, A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0040-z · Cited by 510
Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway
Kwak, M.-K., Wakabayashi, N., Greenlaw, J. L., Yamamoto, M., & Kensler, T. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8786-8794.2003 · Cited by 500
Regulation of proteasome activity in health and disease
Schmidt, M., & Finley, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.012 · Cited by 464
Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop
Steffen, J., Seeger, M., Koch, A., & Krüger, E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.012 · Cited by 369
Self-citationBetarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J.-H., Lund, S., Na, H.-M., Taylor, G., Bence, N. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.003 · Cited by 342
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
Deshaies, R. J. (2014) · BMC Biology · doi:10.1186/s12915-014-0094-0 · Cited by 337
Livneh, I., Cohen-Kaplan, V., Cohen-Rosenzweig, C., Avni, N., & Ciechanover, A. (2016) · Cell Research · doi:10.1038/cr.2016.86 · Cited by 330
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327
“This is most likely attributable to transcriptional activation (Meiners et al., 2003).”
BackgroundA plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism
Groll, M., Schellenberg, B., Bachmann, A. S., Archer, C. R., Huber, R., Powell, T. K., Lindow, S., Kaiser, M., & Dudler, R. (2008) · Nature · doi:10.1038/nature06782 · Cited by 308
Cellular stress response pathways and ageing: intricate molecular relationships
Kourtis, N., & Tavernarakis, N. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.162 · Cited by 302
Bianchi, G., Oliva, L., Cascio, P., Pengo, N., Fontana, F., Cerruti, F., Orsi, A., Pasqualetto, E., Mezghrani, A., Calbi, V., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172734 · Cited by 267
Sha, Z., & Goldberg, A. L. (2014) · Current Biology · doi:10.1016/j.cub.2014.06.004 · Cited by 215
Kaneko, T., Hamazaki, J., Iemura, S.-I., Sasaki, K., Furuyama, K., Natsume, T., Tanaka, K., & Murata, S. (2009) · Cell · doi:10.1016/j.cell.2009.05.008 · Cited by 211
Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy
Myeku, N., & Figueiredo-Pereira, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149252 · Cited by 203
Richert, L., Liguori, M. J., Abadie, C., Heyd, B., Mantion, G., Halkic, N., & Waring, J. F. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007708 · Cited by 136
“It is a multisubunit ubiquitin-dependent holoenzyme with a core complex responsible for hydrolytic activity (20 S core) and a regulatory complex with ATPase activity (19 S regulator) that mediates identification and proper trafficking of peptide substrates into the active site (Meiners et al., 2003).”
BackgroundApoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
Concannon, C. G., Koehler, B. F., Reimertz, C., Murphy, B. M., Bonner, C., Thurow, N., Ward, M. W., Villunger, A., Strasser, A., Kögel, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1209974 · Cited by 95
“Indeed, previous studies have demonstrated transcriptional induction of proteasomal subunits following proteasomal inhibition (Meiners et al., 2003).”
BackgroundThioredoxin Txnl1/TRP32 Is a Redox-active Cofactor of the 26 S Proteasome
Andersen, K. M., Madsen, L., Prag, S., Johnsen, A. H., Semple, C. A., Hendil, K. B., & Hartmann-Petersen, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900016200 · Cited by 88
Ju, D., Wang, X., Xu, H., & Xie, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01787-07 · Cited by 38
The 26S proteasome and initiation of gene transcription.
Durairaj, G., & Kaiser, P. (2014) · Biomolecules · doi:10.3390/biom4030827 · Cited by 34
“While the aforementioned Rpn4 dependent mechanism is restricted to yeast, a similar negative feedback mechanism has been shown to exist in higher mammalian cells [67,68] and is at least partially mediated by nuclear factor erythroid-derived 2-related factor 1 [69].”
BackgroundCurrie, J., Manda, V., Robinson, S. K., Lai, C., Agnihotri, V., Hidalgo, V., Ludwig, R. W., Zhang, K., Pavelka, J., Wang, Z. V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46600-5 · Cited by 29
Currie, J., Manda, V., Robinson, S. K., Lai, C., Agnihotri, V., Hidalgo, V., Ludwig, R. W., Zhang, K., Pavelka, J., Wang, Z. V., et al. (2023) · doi:10.1101/2023.01.04.521821 · Cited by 2
Metadata
- Authors
- Meiners, S., Heyken, D., Weller, A., Ludwig, A., Stangl, K., Kloetzel, P.-M., & Krüger, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 278
- Issue
- 24
- Pages
- 21517-21525
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1991558827
- Cited by
- 318
- References
- 46
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.